%0 Journal Article
%T DNA methylation landscape in pregnancy-induced hypertension: progress and challenges.
%A Deng F
%A Lei J
%A Qiu J
%A Zhao C
%A Wang X
%A Li M
%A Sun M
%A Zhang M
%A Gao Q
%J Reprod Biol Endocrinol
%V 22
%N 1
%D 2024 Jul 8
%M 38978060
%F 4.982
%R 10.1186/s12958-024-01248-0
%X Gestational hypertension (PIH), especially pre-eclampsia (PE), is a common complication of pregnancy. This condition poses significant risks to the health of both the mother and the fetus. Emerging evidence suggests that epigenetic modifications, particularly DNA methylation, may play a role in initiating the earliest pathophysiology of PIH. This article describes the relationship between DNA methylation and placental trophoblast function, genes associated with the placental microenvironment, the placental vascular system, and maternal blood and vascular function, abnormalities of umbilical cord blood and vascular function in the onset and progression of PIH, as well as changes in DNA methylation in the progeny of PIH, in terms of maternal, fetal, and offspring. We also explore the latest research on DNA methylation-based early detection, diagnosis and potential therapeutic strategies for PIH. This will enable the field of DNA methylation research to continue to enhance our understanding of the epigenetic regulation of PIH genes and identify potential therapeutic targets.